ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

Pinkel Corrects Report On ALL – Two Drugs Are Better Than One

April 21, 1978

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions

March 29, 2002

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980

R. Lee Clark Clinic Dedication To Honor M.D. Anderson’s “Architect”

November 13, 1987

Facing Congressional Criticism, NIH Starts Review of Extramural Conflict Policies.

June 13, 2008